Overview
- The Health Cabinet will name compliant and noncompliant companies next week, with withdrawals and reverse‑auction reassignment under consideration.
- National availability is roughly 90% across IMSS, ISSSTE and IMSS‑Bienestar, and oncology delays dropped from 10–15 suppliers to three or four.
- Contract, delivery and payment audits are being finalized by oversight and health agencies, with potential inhabilitations and legal complaints for proven cases.
- Industry groups cite at least 19–20 billion pesos in government arrears since 2021; officials accept pending payments but say debts do not excuse missed deliveries.
- Birmex recently awarded 73.3 million pesos to Médica Farma Arcar for distribution despite earlier ASF observations, as the government readies a Nov. 1 launch of the 2027–2028 tender that will factor past performance.